These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 26987530)

  • 1. Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.
    Terry MB; McDonald JA; Wu HC; Eng S; Santella RM
    Adv Exp Med Biol; 2016; 882():33-68. PubMed ID: 26987530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of DNA repair in breast cancer.
    Nowsheen S; Aziz K; Tran PT; Gorgoulis VG; Yang ES; Georgakilas AG
    Cancer Lett; 2014 Jan; 342(2):213-22. PubMed ID: 22634493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Epigenetic Markers for Precision Medicine.
    Dumitrescu RG
    Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation and breast cancer: A way forward (Review).
    Vietri MT; D'Elia G; Benincasa G; Ferraro G; Caliendo G; Nicoletti GF; Napoli C
    Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34726251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer].
    Noetzel E; Veeck J; Horn F; Hartmann A; Knüchel R; Dahl E
    Pathologe; 2008 Nov; 29 Suppl 2():319-27. PubMed ID: 18807039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.
    Wu J; Zhang Y; Li M
    J Comput Biol; 2019 Dec; 26(12):1394-1408. PubMed ID: 31290690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer Patients.
    Wu ZH; Tang Y; Zhou Y
    Cancer Control; 2021; 28():1073274820988519. PubMed ID: 33504182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers.
    Liu X; Peng Y; Wang J
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32412047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Bastami M; Tavakkoly-Bazzaz J
    Genet Test Mol Biomarkers; 2017 Aug; 21(8):464-470. PubMed ID: 28708432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating Biomarkers in Studies of Chemoprevention.
    Fabian CJ; Kimler BF
    Adv Exp Med Biol; 2016; 882():69-94. PubMed ID: 26987531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.
    Nakamura J; Tanaka T; Kitajima Y; Noshiro H; Miyazaki K
    World J Gastroenterol; 2014 Sep; 20(34):11991-2006. PubMed ID: 25232236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
    Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
    Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel epigenetic signature for overall survival prediction in patients with breast cancer.
    Bao X; Anastasov N; Wang Y; Rosemann M
    J Transl Med; 2019 Nov; 17(1):380. PubMed ID: 31747912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of epigenetics in breast cancer - A review.
    Bhat SA; Majid S; Wani HA; Rashid S
    Cancer Treat Res Commun; 2019; 19():100125. PubMed ID: 30802811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of DNA methylation as biomarkers in the clinical management of lung cancer.
    Fleischhacker M; Dietrich D; Liebenberg V; Field JK; Schmidt B
    Expert Rev Respir Med; 2013 Aug; 7(4):363-83. PubMed ID: 23964627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenome-wide DNA methylation and risk of breast cancer: a systematic review.
    Ennour-Idrissi K; Dragic D; Durocher F; Diorio C
    BMC Cancer; 2020 Oct; 20(1):1048. PubMed ID: 33129307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
    Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
    Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic biomarkers in epithelial ovarian cancer.
    Gloss BS; Samimi G
    Cancer Lett; 2014 Jan; 342(2):257-63. PubMed ID: 22245949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation-based biomarkers in serum of patients with breast cancer.
    Van De Voorde L; Speeckaert R; Van Gestel D; Bracke M; De Neve W; Delanghe J; Speeckaert M
    Mutat Res; 2012; 751(2):304-325. PubMed ID: 22698615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis.
    Zhang W; Wang H; Qi Y; Li S; Geng C
    Sci Rep; 2022 Feb; 12(1):1989. PubMed ID: 35132081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.